The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1599
June 1, 2020
View Complete Issue         Table of Contents 2019 
Talicia - A 3-Drug Combination for Helicobacter pylori Infection
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Talicia - A 3-Drug Combination for Helicobacter pylori Infection
June 1, 2020 (Issue: 1599)
The FDA has approved a fixed-dose combination of omeprazole, amoxicillin, and rifabutin (Talicia – RedHill) for treatment of Helicobacter pylori infection in adults. Talicia is the first rifabutin-based product to be approved for this...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Talicia - A 3-Drug Combination for Helicobacter pylori Infection
Article code: 1599c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.